The potential role of photodynamic therapy in the treatment of malignant melanoma - An in vitro study

Advances in Clinical and Experimental Medicine

Volumn 21, Issue 2, 2012, Pages 179-185

  Choromańska, Anna ^a   Saczko, Jolanta ^a   Kulbacka, Julita ^a   Skolucka, Nina ^a   Majkowski, Michał ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

Apoptosis; Melanoma; Photodynamic therapy; Photofrin

Indexed keywords

CARBONYL DERIVATIVE; HEME OXYGENASE; MANGANESE SUPEROXIDE DISMUTASE; PHOTOFRIN; THIOL GROUP;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIGHT; MELANOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STATISTICAL SIGNIFICANCE;

EID: 84862523179     PISSN: 18995276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Brown SB, Brown EA, Walker I: The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 2004, 5, 497-508.
2. Castano AP, Demidova TN, Hamblin MR: Mechanisms in photodynamic therapy: part two - cellular signaling, cell metabolism and modes of cell death. Photodiag Photodyn Ther 2005, 2, 1-23.
3. Wawrzuta A, Saczko J, Kulbacka J, Chwiłkowska A: Can photodynamic therapy be an alternative method in melanoma treatment? Przegl Dermatol 2009, 96, 240-243.
4. Ramiro DA, Bruno JM, Arselio PC, Carlos BD: Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta 2004, 1704, 59-86.
5. Robertson CA, Hawkins Evans D, Abrahamse H: Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B 2009, 96, 1-8.
6. Lim DS, Ko SH, Lee WY: Silkworm-pheophorbide a mediated photodynamic therapy against B16F10 pigmented melanoma. J Photochem Photobiol B 2004, 74, 1-6.
7. Saczko J, Skrzypek W, Chwilkowska A, Choromanska A, Pola A, Gamian A, Kulbacka J: Photo-oxidative action in cervix carcinoma cells induced by HpD-mediated photodynamic therapy. Exp Oncol 2009, 31, 195-199.
8. Kolagal V, Karanam SA, Dharmavarapu PK, D'Souza R, Upadhya S, Kumar V, Kedage V, Muttigi MS, Shetty JK, Prakash M: Determination of oxidative stress markers and their importance in early diagnosis of uremia-related complications. Indian J Nephrol 2009, 19, 8-12.
9. Dolgachev V, Oberley LW, Huang TT, Kraniak JM, Tainsky MA, Hanada K, Separovic D: A role for manganase superoxide dismutase in apoptosis after photosensitization. Biochem Biophys Res Commun 2005, 332, 411-417.
10. Vile GF, Basu-Modak S, Waltner C, Tyrrell RM: Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci USA 1994, 91, 2607-2610.
11. Moncieff MD, Thompson JF, Quinn M, Stretch JR: Reconstruction after wide excision of primary cutaneous melanomas: part II - the extremities. Lancet Oncol 2009, 10, 810-815.
12. Kusmierz D, Latocha M, Zielinska A, Nawrocka-Musial D, Sliupkas-Dyrda E: The Expression of the Melanogenesis Pathway Genes TYR, TYRP-1, and TYRP-2 and the Synthesis of Melanin in SH-4 Melanoma Cells After Photodynamic Therapy with Photoion. Adv Clin Exp Med 2009, 18, 449-459.
13. Saczko J, Kulbacka J, Chwilkowska A, Drag-Zalesinska M, Wysocka T, Lugowski M, Banas T: The influence of photodynamic therapy on apoptosis in human melanoma cell line. Folia Histochem Cytobiol 2005, 43, 129-132.
14. Saczko J, Chwilkowska A, Kulbacka J, Berdowska I, Zielinski B, Drag-Zalesinska M, Wysocka T, Lugowski M, Banas T: Photooxidative action in cancer and normal cells induced by the use of photofrin in photodynamic therapy. Folia Biol 2008, 54, 24-29.
15. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82, 70-77.
16. Ambrosone CB, Ahn J, Singh KK, Rezaishiraz H, Furberg H, Sweeney C, Coles B, Trovato A: Polymorphisms in Genes Related to Oxidative Stress (MPO, MnSOD, CAT) and Survival After Treatment for Breast Cancer. Cancer Res 2005, 65, 1105-1111.
17. Kolarova H, Macecek J, Nevrelova P, Huf M, Tomecka M, Bajgar R, Mosinger J, Strnad M: Photodynamic therapy with zinc-tetra (p-sulfophenyl) porphyrin bound to cyclodextrin induces single stand breaks of cellular DNA in G361 melanoma cells. Toxicol in Vitro 2005, 19, 971-974.
18. Nowak-Sliwinska P, Karocki A, Elas M, Pawlak A, Stochel G, Urbanska K: Verteporfin, Photofrin II and merocyanine 540 as PDT photosensitizer against melanoma cells. Biochem Biophys Res Commun 2006, 349, 549-555.
19. Radestock A, Elsner P, Gitter B, Hipler UC: Induction of Apoptosis in HaCaT Cells by Photodynamic Therapy with Chlorin e6 or Pheophorbide A. Skin Pharmacol Physiol 2007, 20, 3-9.
20. Woodburn KW, Fan Q, Kessel D, Luo Y, Young SW: Photodynamic Therapy of B16F10 Murine Melanoma with Lutetium Texaphyrin. J Invest Dermatol 1998, 110, 746-751.
21. Yagc R, Ersoz I, Erdurmu M, Gurel A, Duman S: Protein carbonyl levels in the aqueous humour and serum of patients with pseudoexfoliation syndrome. Eye 2008, 22, 128-131.
22. Saczko J, Kulbacka J, Chwilkowska A, Pola A, Lugowski M, Marcinkowska A, Malarska A, Banas T: Cytosolic superoxide dismutase activity after photodynamic therapy, intracellular distribution of Photofrin II and hypericin, and P-glycoprotein localization in human colon adenocarcinoma. Folia Histochem Cytobiol 2007, 45, 93-97.
23. Golab J, Nowis D, Skrzycki M, Czeczot H, Baranczyk-Kuzma A, Wilczynski GM, Makowski M, Mroz P, Kozar K, Kaminski R, Jalili A, Kopec M, Grzela T, Jakobisiak M: Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor. J Biol Chem 2003, 278, 407-414.
24. Hoshidaa S, Nishidab M, Yamashitaa N, Igarashib J, Aokib K, Horia M, Kuzuyab T, Tada M: Heme Oxygenase-1 Expression and Its Relation to Oxidative Stress During Primary Culture of Cardiomyocytes. J Mol Cell Cardiol 1996, 28, 1845-1855.
25. Gomer CJ, Luna M, Ferrario A, Rucker N: Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation. Photochem Photobiol 1991, 53, 275-279.
26. Nowis D, Legat M, Grzela T, Niderla J, Wilczek E, Wilczynski GM, Glodkowska E, Mrowka P, Issat T, Dulak J, Jozkowicz A, Was H, Adamek M, Wrzosek A, Nazarewski S, Makowski M, Stoklosa T, Jakobisiak M, Golab J: Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 2006, 25, 3365-3374.
27. Frank J, Lornejad-Schafer MR, Schoffl H, Flaccus A, Lambert Ch, Biesalski HK: Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy. Int J Oncol 2007, 31, 1539-1545.
28. Chen Y, Zheng W, Li Y, Zhong J, Ji J, Shen P: Apoptosis induced by methylene-blue-mediated photodynamic therapy in melanomas and the involvement of mitochondrial dysfunction revealed by proteomics. Cancer Sci 2008, 99, 2019-2027.
29. Das N, Gupta S, Mazumdar S: Direct Observation of Release of Cytochrome c from Lipid-Encapsulated Protein by Peroxide and Superoxide: A Possible Mechanism for Drug-Induced Apoptosis. Biochem Biophys Res Commun 2001, 286, 311-314.